IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8907101 B1

PDFFull Text
Date of Patent:
Dec. 09, 2014

Filed:

Aug. 16, 2013

Sulfonamide derivatives

Applicants:

Pfizer Limited, Sandwich, GB;

Icagen, Inc., Durham, NC (US);

Inventors:

Serge Beaudoin, Cary, NC (US);

Michael Christopher Laufersweiler, Maineville, OH (US);

Christopher John Markworth, Bellingham, WA (US);

Brian Edward Marron, Durham, NC (US);

David Simon Millan, Sandwich, GB;

David James Rawson, Sandwich, GB;

Steven Michael Reister, Cary, NC (US);

Kosuke Sasaki, Osaka, JP;

Robert Ian Storer, Sandwich, GB;

Paul Anthony Stupple, Sandwich, GB;

Nigel Alan Swain, Sandwich, GB;

Christopher William West, Cary, NC (US);

Shulan Zhou, Chapel Hill, NC (US);

Assignees:

Pfizer Limited, Sandwich, GB;

Icagen, Inc., Durham, NC (US);

Attorney:

J. Michael Dixon

Primary Examiner:

Heidi Reese

Int. Cl.
CPC ...
A61K 31/44 (2006.01); C07D 211/72 (2006.01); C07D 401/00 (2006.01); C07F 9/6539 (2006.01); A61K 31/675 (2006.01); A61K 31/454 (2006.01); C07D 285/08 (2006.01); A61K 31/433 (2006.01); C07D 263/50 (2006.01); A61K 45/06 (2006.01); A61K 31/4439 (2006.01); C07D 413/12 (2006.01); C07D 417/14 (2006.01); A61K 31/501 (2006.01); A61K 31/427 (2006.01); C07D 275/03 (2006.01); A61K 31/506 (2006.01); A61K 31/4545 (2006.01); C07D 401/12 (2006.01); C07D 417/12 (2006.01); A61K 31/496 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); C07F 9/6539 (2013.01); A61K 31/675 (2013.01); A61K 31/454 (2013.01); C07D 285/08 (2013.01); A61K 31/433 (2013.01); C07D 263/50 (2013.01); A61K 45/06 (2013.01); A61K 31/4439 (2013.01); C01D 277/18 (2013.01); C07D 413/12 (2013.01); C07D 417/14 (2013.01); A61K 31/501 (2013.01); A61K 31/427 (2013.01); C07D 275/03 (2013.01); A61K 31/506 (2013.01); A61K 31/4545 (2013.01); C07D 401/12 (2013.01); A61K 31/496 (2013.01);
Abstract

The present invention relates to compounds of the formula and pharmaceutically acceptable salts, solvates or tautomers thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds, and the uses of such compounds, in particular for the treatment of pain.

Find Patent Forward Citations

Loading…